Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-03-08
2011-03-08
Liu, Sue (Department: 1639)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S015000, C435S194000, C530S334000, C548S100000
Reexamination Certificate
active
07901894
ABSTRACT:
The present invention provides a method for identifying inhibitors of protein kinases. Methods are also provided for inhibiting protein kinase activity. Specific non-peptide protein tyrosine kinase inhibitors are provided. The protein kinases produced using the method of the present invention may be used to treat a number of conditions in patients, including cancer, psoriasis, atherosclerosis, or immune system activity.
REFERENCES:
patent: 5464861 (1995-11-01), Dobrusin et al.
patent: 5532167 (1996-07-01), Cantley et al.
patent: 5552534 (1996-09-01), Hirschmann et al.
patent: 5648378 (1997-07-01), Huang
patent: 5705585 (1998-01-01), Hogan, Jr.
patent: 5736412 (1998-04-01), Zambias et al.
patent: 6011175 (2000-01-01), Scbti et al.
patent: 6420338 (2002-07-01), Schneider et al.
patent: 6552066 (2003-04-01), Sharpe et al.
patent: 6747053 (2004-06-01), Gabriel et al.
patent: 7005445 (2006-02-01), Hangauer, Jr. et al.
patent: 7070936 (2006-07-01), Hangauer, Jr. et al.
patent: 7129225 (2006-10-01), Nicotera et al.
patent: 7141596 (2006-11-01), Combs et al.
patent: 2003/0016615 (2003-01-01), Lee et al.
patent: 2004/0019015 (2004-01-01), Nicotera et al.
patent: 2005/0256159 (2005-11-01), Barton et al.
patent: 2006/0030544 (2006-02-01), Hangauer, Jr. et al.
patent: 2006/0122197 (2006-06-01), Yao et al.
patent: 2006/0172971 (2006-08-01), Nicotera et al.
patent: 2008/0004241 (2008-01-01), Hangauer
patent: 43 07 883 (1993-09-01), None
patent: 0 370 381 (1990-05-01), None
patent: 0 463 638 (1992-01-01), None
patent: 0 846 464 (1998-06-01), None
patent: 0974584 (2000-01-01), None
patent: S45-39538 (1970-12-01), None
patent: WO 91/09849 (1991-07-01), None
patent: WO 96/35805 (1996-11-01), None
patent: WO 96/39384 (1996-12-01), None
patent: WO 96/39385 (1996-12-01), None
patent: WO 97/29091 (1997-08-01), None
patent: WO 98/07695 (1998-02-01), None
patent: WO 98/27108 (1998-06-01), None
patent: WO 9915500 (1999-04-01), None
patent: WO 99/34018 (1999-07-01), None
patent: WO 99/48868 (1999-09-01), None
patent: WO-9954309 (1999-10-01), None
patent: WO-9959973 (1999-11-01), None
patent: WO-0042213 (2000-07-01), None
patent: WO-0116097 (2001-03-01), None
patent: WO 01/53274 (2001-07-01), None
patent: WO 01/55111 (2001-08-01), None
patent: WO-0160814 (2001-08-01), None
patent: WO 01/85726 (2001-11-01), None
patent: WO 01/98290 (2001-12-01), None
patent: WO 02/00661 (2002-01-01), None
patent: WO 02/04459 (2002-01-01), None
patent: WO 02/072548 (2002-09-01), None
patent: WO 02/080926 (2002-10-01), None
patent: WO 02/080926 (2002-10-01), None
patent: WO-03086385 (2003-03-01), None
patent: WO 03/093297 (2003-11-01), None
patent: WO 03/093297 (2003-11-01), None
patent: WO-2004022525 (2004-03-01), None
patent: WO 2004/056774 (2004-07-01), None
patent: WO 2005/032493 (2005-04-01), None
patent: WO 2007/026920 (2007-03-01), None
Terent'ev et al., Chemistry of Heterocyclic Compounds. p. 455; Apr. 23, 1966.
Pigulla et al., Archiv der Pharmazie. vol. 312(1): 12-18; 1979.
Kuehm-Caubere et al., J. Med. Chem. vol. 40: 1201-1210; 1997.
Huang et al., “Polyhydroxylated 3-(N-Phenyl) Carbamoyl-2-Iminochromene Derivatives as Potent Inhibitors of Tyrosine Kinase p60c-src”,Bioorganic&Medicinal Chemistry Letters5(20):2423-2428 (1995).
Casnellie et al.Adv. Enzyme Regul., 22:501-515 (1984).
Engström et al.Meth. Enzymol., 107:130-154 (1984).
Fukunaga et al. Protein Phosphorylation, Second Edition, Chapter 13, pp. 291-313 (1999).
Kemp et al.TIBS, 15:342-346 (1990).
Kemp et al.Meth. Enzymol., 200:121-134 (1991).
Marsilje et al.Bioorg. Med. Chem. Lett., 10:477-481 (2000).
Metfalf III et al.Curr. Pharm. Design, 8:2049-2075 (2002).
Milkiewicz et al.Bioorg. Med. Chem. Lett., 10:483-486 (2000).
Pearson et al.Meth. Enzymol., 200:62-81 (1991).
Ruzzene et al.Protein Phosphorylation, Second Edition, Chapter 10, pp. 221-253 (1999).
SawyerExpert Opin. Investig. Drugs, 13(1):1-19 (2004).
ShoichetNature, 432:862-865 (2004).
Songyang et al.Meth. Mol. Biol., 87:87-98 (1998).
Sparks et al.Int. J. Biochem., 18(6)497-504 (1986).
Chemical Abstracts vol. 67, No. 1 (1967) abstract No. 1850x (Chi-Ting Chou) p. 166 & Yao Hsueh Ao, vol. 13, No. 6 (1966).
Hoover et al.J. Med. Chem., 41(16):2934-2938 (1998).
Patent Abstracts of Japan vol. 013, No. 384 (1989) & JP 01 132579 A (SS Pharmaceut. CO. LTD.) abstract only (1989).
Poulain et al.J. Med. Chem., 44(21):3378-3390 (2001).
Romero et al.J. Med. Chem., 37(7):999-1014 (1994).
Supplementary Partial European Search Report for EP 02 77 3833, mailed Sep. 29, 2005.
Al-Obeidi et al., “Protein Tyrosine Kinases: Structure, Substrate Specificity, and Drug Discovery”,Biopoly, 47:197-223 (1998).
Bishop et al., “Screening a Hydroxystilbene Library for Selective Inhibition of the B Cell Antigen Receptor Kinase Cascade”,Tetrahedron, 53(35):11995-12004 (1997).
Budde et al., “Discovery, Development, and Testing of Substrates and Inhibitors of PP60C-SRC”,Int. J. Pharmacognosy, 33:27-34 (1995).
Dolle, R. E., “Discovery of enzyme inhibitors through combinatorial chemistry”,Mol. Diversity, 2:223-236 (1996).
Lawrence et al., “Protein Kinase Inhibitors: The Tyrosine-Specific Protein Kinases”,Pharmacol. Ther., 77(2):81-114 (1998).
Norman et al., “A Structure-Based Library Approach to Kinase Inhibitors”,J. Am. Chem. Soc., 118:7430-7431 (1996).
Stahura et al., “Molecular scaffold-based design and comparison of combinatorial libraries focused on the ATP-binding site of protein kinases”,J. Mol. Graphics Modelling, 17:1-9 (1999).
Sun et al., “CombiDOCK: Structure-based combinatorial docking and library design”,J. Computer-Aided Mol. Des., 12:597-604 (1998).
Taylor et al., “Protein kinase inhibition: natural and synthetic variations on a theme”,Curr. Opin. Chem. Biol., 1:219-226 (1997).
Tegge et al., “Analysis of protein kinase substrate specificity by the use of peptide libraries on cellulose paper (SPOT-Method)”,Meth. Mol. Biol., 87:99-106 (1998).
Alfaro-Lopez et al.J. Med. Chem., 41:2252-2260 (1998).
Burke et al.J. Med. Chem., 36(4):425-432 (1993).
Burke, et al.Acc. Chem. Res., 36:426-433 (2003).
Choi “Development of a Cellular Mimetic Protein Kinase Assay and a Novel Methodology for Determining the Mode of Inhibition for Multisubstrate” thesis, Bell & Howell Co., Aug. 1999.
Faltynek et al.Biochem., 34:12404-12410 (1995).
Fry et al.Science, 265:1093-1095 (1994).
Hanke et al.J Biol. Chem., 271(2):695-701 (1996).
Hsiao et al.Synthesis, pp. 1043-1046 (1998).
HubbardEMBO J., 16(18):5572-5581 (1997).
Johnson, et al.,Nature Reviews, 1:696-709 (2002).
Kim et al.Int. J. Peptide Protein Res., 44:457-465 (1994).
Lai et al.J. Org. Chem., 61:1872-1874 (1996).
Lai et al.J. Peptide Res., 51:271-281 (1998).
Levitzki et al.Science, 267:1782-1788 (1995).
Levitzki,Acc. Chem. Res., 36:462-469 (2003).
Lou et al.Bioorg. Med. Chem., 4(5):677-682 (1996).
McCluskey, et al.J. Med Chem., 45:1151-1175 (2002).
Mohammadi et al.Science, 276:955-960 (1997).
Nair et al.J. Med. Chem., 38:4276-4283 (1995).
Nair et al.Synthesis, pp. 810-814 (1995).
Patrick et al.DDT, 1(8):325-330 (1996).
Pestell, et al.Oncogene, 19:6607-6612 (2000).
Ramdas et al.Arch. Biochem. Biophys., 323(2):237-242 (1995).
Rewcastle et al.J. Med. Chem., 39:1823-1835 (1996).
Saperstein et al.Biochem., 28:5694-5701 (1989).
Sawutz et al.Biochem. Pharmacol., 51:1631-1638 (1996).
Showalter et al.Pharmacol. Ther., 76(1-3):55-71 (1997).
Susa, et al.,TiPS, 21:489-495 (2000).
Thakkar et al.J. Med. Chem., 36:2950-2955 (1993).
Xu et al.Nature, 385:595-602 (1997).
Zhang,Annu. Rev. Pharmacol. Toxicol., 42:209-234 (2002).
Zheng et al.Biochem., 32:2154-2161 (1993).
“Amersham Pharmacia Biotech to Market and Distribute BioFocus' SoftFocus(TM) Kinase Libraries in North America,” News release: Nov. 23, 1999.
Abram et al., “Src Family Tyrosine Kinases and Growth Factor Signaling,”Experimental Cell Research, 254:1-13 (2000).
Bakhtiar et al., “Quantification of the Anti-Leukemia Drug STI1571
Hangauer David G.
Milkiewicz Karen L.
Elrifi Ivor R.
Erlacher Heidi A.
Liu Sue
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
The Research Foundation of State University of New York
LandOfFree
Kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2736466